NUWIQ
Biological
Octapharma USA, Inc.
Total Payments
$1.1M
Transactions
1,356
Doctors
296
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $114,777 | 164 | 32 |
| 2023 | $114,365 | 204 | 69 |
| 2022 | $33,779 | 77 | 44 |
| 2021 | $71,026 | 129 | 62 |
| 2020 | $15,803 | 49 | 30 |
| 2019 | $138,563 | 295 | 93 |
| 2018 | $245,106 | 254 | 57 |
| 2017 | $336,654 | 184 | 30 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $470,087 | 153 | 43.9% |
| Honoraria | $319,438 | 120 | 29.9% |
| Travel and Lodging | $198,615 | 454 | 18.6% |
| Consulting Fee | $45,865 | 46 | 4.3% |
| Food and Beverage | $33,145 | 571 | 3.1% |
| Grant | $2,500 | 1 | 0.2% |
| Education | $422.12 | 11 | 0.0% |
Payments by Type
General
$599,985
1,203 transactions
Research
$470,087
153 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Gena-21b | Octapharma USA, Inc. | $120,638 | 0 |
| Gena-05 | Octapharma USA, Inc. | $118,264 | 0 |
| GENA-21b | Octapharma USA, Inc. | $102,902 | 0 |
| GENA-05 | Octapharma USA, Inc. | $52,387 | 5 |
| Gena-99 | Octapharma USA, Inc. | $44,741 | 0 |
| GENA-22 | Octapharma USA, Inc. | $15,346 | 3 |
| GENA-25 | Octapharma USA, Inc. | $11,419 | 0 |
| Gena-15 | Octapharma USA, Inc. | $4,390 | 0 |
Top Doctors Receiving Payments for NUWIQ — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.D | Maternal & Fetal Medicine | Durham, NC | $7,552 | 11 |
| , MD | Pediatric Hematology-Oncology | Atlanta, GA | $7,102 | 11 |
| , M.D | Internal Medicine | Detroit, MI | $7,053 | 3 |
| , M.D | Pediatrics | Peoria, IL | $6,120 | 16 |
| , MD | Blood Banking & Transfusion Medicine | Durham, NC | $5,387 | 11 |
| , M.D | Pediatric Hematology-Oncology | New York, NY | $5,332 | 10 |
| , MD | Pediatrics | New Orleans, LA | $4,931 | 12 |
| , M.D | Pediatric Hematology-Oncology | Las Vegas, NV | $4,649 | 10 |
| , MD, MPH | Hematology | Boston, MA | $4,567 | 7 |
| , MD | Pediatrics | Duarte, CA | $4,562 | 13 |
| , MD | Pediatric Hematology-Oncology | Orange, CA | $4,430 | 11 |
| , MD | Pediatrics | Detroit, MI | $4,321 | 8 |
| , M.D | Pediatric Hematology-Oncology | Metairie, LA | $4,293 | 16 |
| , M.D | Pediatric Hematology-Oncology | Madera, CA | $4,125 | 8 |
| , MD | Pediatric Hematology-Oncology | Gainesville, FL | $4,069 | 9 |
| , M.D | Pediatrics | Nashville, TN | $4,060 | 9 |
| , M.D | Hematology & Oncology | Atlanta, GA | $4,001 | 10 |
| , MD | Pediatric Hematology-Oncology | Beaufort, SC | $3,977 | 9 |
| , M.D | Student in an Organized Health Care Education/Training Program | Houston, TX | $3,961 | 17 |
| , M.D | Pediatrics | Chicago, IL | $3,877 | 13 |
| , DNP | Family | Fargo, ND | $3,849 | 7 |
| , M.D | Hematology | Atlanta, GA | $3,798 | 7 |
| , MD | Student in an Organized Health Care Education/Training Program | Chapel Hill, NC | $3,794 | 8 |
| , MD | Pediatrics | Buffalo, NY | $3,792 | 10 |
| , MD | Pediatric Hematology-Oncology | Houston, TX | $3,792 | 10 |
Ad
Manufacturing Companies
- Octapharma USA, Inc. $1.1M
Product Information
- Type Biological
- Total Payments $1.1M
- Total Doctors 296
- Transactions 1,356
About NUWIQ
NUWIQ is a biological associated with $1.1M in payments to 296 healthcare providers, recorded across 1,356 transactions in the CMS Open Payments database. The primary manufacturer is Octapharma USA, Inc..
Payment data is available from 2017 to 2024. In 2024, $114,777 was paid across 164 transactions to 32 doctors.
The most common payment nature for NUWIQ is "Unspecified" ($470,087, 43.9% of total).
NUWIQ is associated with 8 research studies, including "Gena-21b" ($120,638).